This week, Caszyme is attending the Alliance for Regenerative Medicine’s Cell & Gene Meeting on the Med, bringing together Europe’s cell and gene therapy community to explore emerging innovations and discuss the future of advanced therapies.
We look forward to contributing to this dialogue by sharing more about Caszyme’s gene editing expertise and highlighting our novel Cas12l platform.
Join us on Wednesday, April 29, at 13:45 CET for our company presentation, delivered by CEO, Dr. Giedrius Gasiunas.
Beyond the sessions, we are looking forward to in-person conversations.
If you’re attending, let’s connect!